• The product portfolio of Spring Bioscience Corporation to be licensed to Abcam for research use only (RUO) applications
• The portfolio includes 243 recombinant rabbit monoclonal antibodies

Cambridge, UK, 22 January 2018: Abcam plc (“Abcam”), a global leader in the supply of life science research tools, is pleased to announce that it has entered into a definitive license agreement with Roche. Under the terms of the agreement Abcam will obtain the exclusive rights to the product portfolio of Spring Bioscience Corporation (“Spring”) in the research use only (RUO) field of use, comprising a total of approximately 760 unique products (the “Spring Portfolio”). Roche, which acquired Spring in 2007, will retain the antibody development capabilities and rights pertaining to the Spring Portfolio for internal research, companion diagnostic and IVD uses.

The core portfolio consists of 243 recombinant rabbit monoclonal antibodies, branded Spring Proprietary Clones (SP Clones), which have been optimised for immunohistochemistry (IHC). In addition to the SP Clones, the agreement covers approximately 500 additional products, predominantly other monoclonal and polyclonal antibodies. All products will be sold under the Abcam brand, inclusive of SP branding, and are expected to be available through Abcam.com from 21 February 2018.

Financial terms of the agreement have not been disclosed.

Alan Hirzel, CEO, of Abcam said:“This agreement represents an exciting step in the ongoing collaborative and long-term relationship between Abcam and Roche. By incorporating the Spring Bioscience antibodies into our portfolio, we will be able to better assist our customers, providing them with more products for their most important targets, faster. Abcam is excited to partner with Spring Bioscience, commonly recognised as a leading manufacturer of IHC antibodies, furthering Abcam’s mission to provide customers with the highest quality recombinant antibodies for their research.”

For further information, please contact:

Abcam
T: +44 (0) 1223 696 000
Alan Hirzel, Chief Executive Officer
Gavin Wood, Chief Financial Officer
James Staveley, Head of Investor Relations

About Abcam

As an innovator in reagents and tools, Abcam’s purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways.Already a pioneer in data sharing and ecommerce in the life sciences, Abcam’s ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world’s 750,000 life science researchers use Abcam’s affinity binders, reagents, biomarkers and assays and the Company’s products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. By actively listening to and collaborating with researchers, the Company continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results. Abcam’s eleven locations are in the world’s leading life science research hubs, enabling local services and multi-language support. Founded in 1998 and headquartered in Cambridge, UK, the Company sells to more than 130 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).

To find out more, go to https://www.abcam.com and https://www.abcamplc.com

About Spring Bioscience

Founded in 2001 by scientists with a primary focus on immunohistochemistry (IHC), Spring Bioscience Corporation (Spring) serves as an antibody centre of excellence, for developing and manufacturing rabbit monoclonal antibodies designed for use in IHC. Spring, which was acquired by Roche in 2007, has developed a proprietary antibody menu of highly-sensitive Spring Proprietary Clones (“SP Clones”) that yield specificity and consistency for use in research.

Forward looking statementsThis announcement, including any information included or incorporated by reference in this announcement, may contain forward-looking statements (including words such as “believe”, “expect”, “estimate”, “intend”, “anticipate” and words of similar meaning) which are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Abcam Group. All statements other than statements of historical facts may be forward-looking statements and should not be treated as guarantees of future performance. These forward-looking statements involve risks and uncertainties, many of which are beyond the control of the Abcam Group, and there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These forward-looking statements speak only as at the date of this announcement and accordingly undue reliance should not be placed on such statements. The Abcam Group does not assume any obligation to, and does not intend to, revise or update these forward-looking statements, except as required pursuant to applicable law.

• New range offers increased choice for multi-colour staining

Cambridge, UK, November 04 2013: Abcam Plc., a leading provider of protein research tools and services, announced today that it has added new Alexa Fluor^® 405/568/750 conjugated secondary antibodies to its existing Alexa Fluor® 488/555/594/647 conjugates. Extensively tested in Abcam’s labs, the Alexa Fluor^® range guarantees bright staining and low background. The different color variants were selected to provide an increased selection for multi-color staining.

The Alexa Fluor^® portfolio comprises antibodies raised against mouse/rabbit/rat/chicken /goat /sheep/guinea-pig IgG and against mouse/rabbit IgM. It also includes a large selection of pre-adsorbed/cross-adsorbed and F(ab’)2 fragment secondaries to ensure low species cross-reactivity. A dilution range of 1/200 -1/1000 in IF/ICC allows for at least 250 stainings* per product to improve cost efficiency.

“The Alexa^® range expansion adds a blue emitting fluorophore, Alexa Fluor^® 405, and a near IR dye, Alexa Fluor^® 750. The addition of Alexa Fluor^® 568 is ideal for confocal laser-scanning microscopists as most of these microscopes have a 561nm laser, which optimally excites the Alexa Fluor^® 568 dye. We’re pleased that we can offer our customers more dye variants and enable them to perform multi-colour imaging experiments”.

– Judith Langenick, Product Manager, Secondary Antibodies

Abcam Alexa Fluor^® secondaries are ideal for cell biologists and microscopists undertaking multi-color staining from all research backgrounds. The addition of these products complements Abcam’s innovative RabMAb® (rabbit monoclonal antibodies) products and market leading primary antibody range.

Abcam Alexa Fluor^® secondaries are accompanied with information-rich datasheets, fast delivery, and expert scientific support. They are available globally and can be purchased directly through the Abcam website or through one of Abcam’s authorized distributors.

Find out more about our Alexa Fluor^® range »

---

*assuming a 1/200 dilution in 200 μl PBS

Alexa Fluor^® is a registered trademark of Life Technologies. Alexa Fluor^® dye conjugates contain(s) technology licensed to Abcam by Life Technologies.

• Three lucky labs celebrate Abcam’s tenth anniversary

Dr Fumiko, (Pathology Institute, Tokyo), Dr Koh (Johns Hopkins University) and Dr Smit-Rigter (University of Amsterdam) were announced as the winners of our birthday competition.

Read the full Abcam story.

Create an Abcam account in January and we’ll donate $2 to MSF

For every new scientist that registers on our website in January we will give $2 to Médecins Sans Frontières (MSF).

** Register now! **

Simply fill in the short online form with your details. It should only take only 1-2 minutes. This will create your own personal Abcam account, allowing you to subscribe to our free email update service and personalise your emails to your specific interest areas. It also allows you to claim Abpoints for purchases or customer reviews (Abreviews) of our antibodies.

Tell your friends too!

We will donate $2 to MSF for every new registration in January, up to a maximum of $2000.

Médecins Sans Frontières (MSF) is an international humanitarian medical aid organisation committed to providing medical aid wherever needed, regardless of race, religion, politics or sex. In carrying out humanitarian assistance, MSF seeks also to raise awareness of the crisis situations of the people they help.

• More information about Médecins Sans Frontières
• Register now for Abcam to donate $2